We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
-5.47%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$3.64B
AUM Growth
-$258M
Cap. Flow
-$28M
Cap. Flow %
-0.77%
Top 10 Hldgs %
31.5%
Holding
1,117
New
20
Increased
149
Reduced
280
Closed
111

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$32.6M
2
V icon
Visa
V
+$14.1M
3
BSCQ icon
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
+$12.7M
4
DVY icon
iShares Select Dividend ETF
DVY
+$11.2M
5
HPQ icon
HP
HPQ
+$11.1M

Top Sells

Rank Stock Value
1
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$42.6M
2
JPM icon
JPMorgan Chase
JPM
+$23M
3
AXP icon
American Express
AXP
+$21.8M
4
ADBE icon
Adobe
ADBE
+$10.8M
5
BSCP
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 25.41%
2 Healthcare 21.78%
3 Financials 10.83%
4 Consumer Discretionary 10.02%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VREX icon
826
Varex Imaging
VREX
$460M
$7K ﹤0.01%
320
– –
ARKW icon
827
ARK Web x.0 ETF
ARKW
$1.64B
$6K ﹤0.01%
135
– –
BLUE
828
DELISTED
bluebird bio
BLUE
$6K ﹤0.01%
50
– –
CMS icon
829
CMS Energy
CMS
$23.1B
$6K ﹤0.01%
111
– –
EXAS
830
DELISTED
Exact Sciences
EXAS
$6K ﹤0.01%
200
– –
GSAT icon
831
Globalstar
GSAT
$10.2B
$6K ﹤0.01%
249
– –
HLNE icon
832
Hamilton Lane
HLNE
$3.63B
$6K ﹤0.01%
100
-600
-86% -$42.4K
HSBC icon
833
HSBC
HSBC
$355B
$6K ﹤0.01%
225
– –
IBKR icon
834
Interactive Brokers
IBKR
$40.9B
$6K ﹤0.01%
384
– –
KLAC icon
835
KLA
KLAC
$275B
$6K ﹤0.01%
190
-800
-81% -$27.7K
MNST icon
836
Monster Beverage
MNST
$91.4B
$6K ﹤0.01%
144
-12
-8% -$553
NEOG icon
837
Neogen
NEOG
$2.05B
$6K ﹤0.01%
418
– –
OTTR icon
838
Otter Tail
OTTR
$3.88B
$6K ﹤0.01%
100
– –
PINS icon
839
Pinterest
PINS
$12.4B
$6K ﹤0.01%
253
– –
RNG icon
840
RingCentral
RNG
$4.05B
$6K ﹤0.01%
150
– –
RSPH icon
841
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$741M
$6K ﹤0.01%
230
– –
STM icon
842
STMicroelectronics
STM
$46B
$6K ﹤0.01%
200
– –
VEEV icon
843
Veeva Systems
VEEV
$30.3B
$6K ﹤0.01%
38
– –
WU icon
844
Western Union
WU
$2.57B
$6K ﹤0.01%
433
– –
X
845
DELISTED
US Steel
X
$6K ﹤0.01%
304
– –
TFFP
846
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$6K ﹤0.01%
60
– –
DOC
847
DELISTED
PHYSICIANS REALTY TRUST
DOC
$6K ﹤0.01%
400
– –
BRKR icon
848
Bruker
BRKR
$9.2B
$5K ﹤0.01%
100
– –
DOCU
849
DocuSign
DOCU
$9.63B
$5K ﹤0.01%
100
– –
FNF icon
850
Fidelity National Financial
FNF
$13.9B
$5K ﹤0.01%
132
– –
32 33
34
35 36

Similar funds

AIM
Adapt Investment Managers Geneva, Switzerland $7.56B AUM 29.66% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
OPERF
Oregon Public Employees Retirement Fund Tigard, Oregon $7.58B AUM 27.19% 1-Year Est. Return
SP
SIH Partners Wilmington, Delaware $7.58B AUM 5.28% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return

HM Payson & Co's Q3 2022 Portfolio in Review

As of Q3 2022, HM Payson & Co held 1,117 positions worth $3.64B, down 6.6% from $3.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

HM Payson & Co's Q3 2022 filing shows 20 new, 149 increased, 280 reduced and 111 closed positions. Its largest new stake was Invesco BulletShares 2026 Corporate Bond ETF: 658,565 shares worth $12.3M. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $42.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q3 2022 buy was Invesco BulletShares 2026 Corporate Bond ETF: 658,565 shares worth $12.3M.
  • HM Payson & Co added most to Bristol-Myers Squibb in Q3 2022, an estimated $32.6M increase.
  • HM Payson & Co's biggest Q3 2022 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $42.6M.
  • HM Payson & Co fully exited PIMCO Enhanced Short Maturity Active ESG ETF in Q3 2022, selling an estimated $3.28M.
  • HM Payson & Co's ten largest holdings make up 32% of its $3.64B portfolio in Q3 2022.
  • HM Payson & Co opened 20 new positions and closed 111 in Q3 2022.
  • HM Payson & Co's portfolio value fell 6.6% quarter-over-quarter to $3.64B.

Based on HM Payson & Co's 13F filing for Q3 2022, filed 25 Oct 2022.